Cases & Investigations
Cornerstone Therapeutics Inc. Stockholder Litigation

Overview

Overview Case Updates

Type: Notable Cases

Case Number: 8922

Court: Delaware Chancery Court

Settlement Amount: $17,900,000

Wolf Popper was appointed as a lead counsel to represent the class of Cornerstone Therapeutics Inc. stockholders in a case arising from Cornerstone’s acquisition by its majority shareholder: Chiesi Farmaceutici SpA., which had already owned a 65 percent stake. In the suit, Cornerstone and individual directors were accused of selling the company at an unfair price in breach of their fiduciary duties.

Contact Instructions

Email: outreach@wolfpopper.com
Case Inquiries

Delaware Chancery Court Approves $17.9 Million Settlement for Minority Stockholders of Cornerstone Therapeutics

Case Update | 1/26/2017

Wolf Popper Defeats Motion to Dismiss in Cornerstone Therapeutics Stockholder Litigation

Case Update | 9/10/2014

Cases & Investigations:

Related Attorneys

Related Practice Areas

Corporate Transactional / Derivative Litigation

You may share a link to this page on any of the sites listed below or send link via email:

Cases & Investigations Cornerstone Therapeutics Inc. Stockholder Litigation

Related Attorneys

Related Practice Areas

Cases & Investigations
Cornerstone Therapeutics Inc. Stockholder Litigation